Molecular docking study of active diazenyl scaffolds as inhibitors of essential targets towards antimicrobial drug discovery.

CONCLUSION: Hence, these compounds can be developed as novel antibacterial agents as potent DNA topoisomerase inhibitors and antifungal agents as CYP51 inhibitors.
PMID: 31215386 [PubMed - as supplied by publisher]

Source: Current Drug Targets - June 17, 2019 Category: Drugs & Pharmacology Authors: Kaur H, Gahlawat S, Singh J, Narasimhan B Tags: Curr Drug Targets Source Type: research